Scientific Workshop on Genomic Toxicities of Gene and Cell Therapies
Program: Scientific Workshops
Session: Understanding Immediate Toxicities of Current Gene and Cell Therapy Tools
Program: Scientific Workshops
Session: Understanding Immediate Toxicities of Current Gene and Cell Therapy Tools
Friday, December 6, 2024, 2:03 PM-3:00 PM
Disclosures: Gill: Mission Bio: Membership on an entity's Board of Directors or advisory committees; Asher Biotherapeutics: Research Funding; Novartis: Patents & Royalties, Research Funding; Carisma: Current holder of stock options in a privately-held company; Interius: Current holder of stock options in a privately-held company, Research Funding.
See more of: Understanding Immediate Toxicities of Current Gene and Cell Therapy Tools
See more of: Scientific Workshop on Genomic Toxicities of Gene and Cell Therapies
See more of: Scientific Workshops
See more of: Scientific Workshop on Genomic Toxicities of Gene and Cell Therapies
See more of: Scientific Workshops